PMU65 - COST-MINIMIZATION ANALYSIS OF SMOFKABIVEN® CENTRAL FOR ADULT PATIENTS WITH IMPOSSIBLE, INSUFFICIENT OR CONTRAINDICATED ORAL OR ENTERAL NUTRITION VERSUS STANDARD ENDOVASCULAR TREATMENT IN THE MEXICAN PUBLIC HEALTHCARE SYSTEM

Oct 1, 2018, 00:00 AM
10.1016/j.jval.2018.09.1901
https://www.valueinhealthjournal.com/article/S1098-3015(18)35203-3/fulltext
Section Title :
Section Order : 1260
First Page :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(18)35203-3&doi=10.1016/j.jval.2018.09.1901
HEOR Topics :
Tags :
Regions :